Paroxetine and improvement of visual hallucinations in patients with dementia with Lewy bodies [5]

Journal of the American Geriatrics Society

Volumn 53, Issue 4, 2005, Pages 732-733

  Tanaka, Makoto ^a   Kita, Toru ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

AGED; CASE REPORT; CLINICAL FEATURE; DEMENTIA; FEMALE; HUMAN; LETTER; LEWY BODY; MALE; VISUAL HALLUCINATION; DIFFUSE LEWY BODY DISEASE; HALLUCINATION;

AGED; AGED, 80 AND OVER; FEMALE; HALLUCINATIONS; HUMANS; LEWY BODY DISEASE; MALE; PAROXETINE; SEROTONIN UPTAKE INHIBITORS;

EID: 18944381967     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.53228_5.x     Document Type: Letter

References (10)

1. McKeith IG, Galasko D, Kosaka K et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
2. Mosimann UP, McKeith IG. Dementia with Lewy bodies-diagnosis and treatment. Swiss Med Wkly 2003;133:131-142.
3. McKeith I, Mintzer J, Aarsland D et al. Dementia with Lewy bodies. Lancet Neurol 2004;3:19-28.
4. McKeith I, Fairbairn A, Perry R et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-678.
5. Burke WJ, Pfeiffer RF, McComb RD, Neuroleptic sensitivity to clozapine in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 1998;10:227-229.
6. Shea C, MacKnight C, Rockwood K, Donepezil for treatment of dementia with Lewy bodies: A case series of nine patients. Int Psychogeriatr 1998;10:229-238.
7. Lanctot KL, Herrmann N. Donepezil for behavioural disorders associated with Lewy bodies: A case series. Int J Geriatr Psychiatry 2000;15:338-345.
8. Samuel W, Caligiuri M, Galasko D et al. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: A preliminary study. Int J Geriatr Psychiatry 2000;15:794-802.
9. McKeith I, Del Series T, Spano P et al. Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study. Lancet 2000;356:2031-2036.
10. Grace J, Daniel S, Stevens T et al. Long-term use of rivastigmine in patients with dementia with Lewy bodies: An open-label trial. Int Psychogeriatr 2001; 13:199-205.